Milestone Pharmaceuticals Inc. (MIST) Social Stream
MILESTONE PHARMACEUTICALS INC (MIST) Price Targets From Analysts
Use the tables below to see what analysts covering MILESTONE PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-28 | 3 | $20 | $8 | $13.6 | $1.72 | 690.7% |
| 2022-03-28 | 4 | $20 | $8 | $13.6 | $1.72 | 690.7% |
| 2022-03-29 | 5 | $20 | $8 | $13.6 | $1.72 | 690.7% |
| 2022-04-22 | 5 | $20 | $10 | $14 | $1.72 | 713.95% |
| 2022-05-12 | 5 | $20 | $10 | $14.2 | $1.72 | 725.58% |
| 2022-10-03 | 5 | $20 | $10 | $14.4 | $1.72 | 737.21% |
| 2022-11-10 | 5 | $20 | $10 | $15.4 | $1.72 | 795.35% |
| 2023-03-09 | 4 | $25 | $10 | $16.5 | $1.72 | 859.3% |
| 2023-03-31 | 4 | $25 | $12 | $17 | $1.72 | 888.37% |
| 2023-05-23 | 5 | $25 | $12 | $16.75 | $1.72 | 873.84% |
| 2023-08-10 | 5 | $25 | $4 | $14.2 | $1.72 | 725.58% |
| 2023-10-24 | 5 | $25 | $4 | $13.8 | $1.72 | 702.33% |
| 2023-11-14 | 5 | $25 | $3 | $13.6 | $1.72 | 690.7% |
| 2023-12-27 | 5 | $25 | $3 | $10.8 | $1.72 | 527.91% |
The Trend in the Analyst Price Target
MIST's average price target has moved down $4.6 over the prior 14 months.
Over the past 43 weeks, MIST's average upside potential has been 345.15%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-09 | 5 | 25 | 10 | 16.5 | 3.54 | 366.1% |
| 2023-03-31 | 5 | 25 | 8 | 15.5 | 3.94 | 293.4% |
| 2023-03-31 | 4 | 25 | 12 | 17.0 | 3.94 | 331.47% |
| 2023-08-10 | 5 | 25 | 4 | 14.2 | 3.30 | 330.3% |
| 2023-12-27 | 5 | 25 | 3 | 10.8 | 1.88 | 474.47% |
MIST Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.4 | 4 | 0 | 1 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
MIST's average broker recommendation rating worsened by 0.4 over the prior 16 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- MIST has a higher upside potential (average analyst target price relative to current price) than 1729.59% of all US stocks.
- In the context of all US stocks, MILESTONE PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1450.35% of them.
- MIST has a higher number of analysts covering the stock than 404.07% of Healthcare stocks.
- MILESTONE PHARMACEUTICALS INC's average analyst price target is higher than 472.27% of Healthcare stocks.
Stocks similar to MILESTONE PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CYCN, APM, and CLVR.
View All Top Stocks by Price Target
Is MIST a Buy, Hold or Sell? See the POWR Ratings now!